Understanding the Vagus Nerve: The Communication Pathway Between Gut and Brain

Exploring the bidirectional highway linking your digestive system to your brain

The vagus nerve — derived from the Latin word for “wandering” — is the longest cranial nerve in the human body. It travels from the brainstem through the neck and thorax, branching to innervate the heart, lungs, and gastrointestinal tract. In the context of gut-brain science, its role in bidirectional communication between the digestive system and the central nervous system has attracted considerable research interest.

Bidirectional signalling

The vagus nerve carries signals in two directions. Approximately 80–90% of its fibres are afferent — they carry sensory information from the gut to the brain. The remainder are efferent, transmitting signals from the brain to the gut and other organs. This predominantly ascending signal traffic suggests that the gut plays a larger role in informing the brain than was historically appreciated.

Research in this area has explored associations between vagal signalling and processes including satiety regulation, inflammatory responses, and mood. The mechanisms involved are complex and not yet fully understood, and the research base includes a mixture of preclinical and early human evidence.

The gut microbiome and vagal activation

Emerging research has examined whether microbial metabolites and gut-derived signals can influence vagal activity. Short-chain fatty acids (SCFAs), produced by microbial fermentation of dietary fibre, have been investigated as potential signalling molecules at the gut-brain interface, including at enteroendocrine cells that communicate with vagal afferents.

This is an area of active investigation, and translating mechanistic findings into practical applications remains a significant scientific challenge.

Implications for formulation science

At WellThesis, we consider vagal signalling pathways as one component of the broader gut-brain axis framework that informs our formulation rationale. We do not claim that our formulations directly modulate vagal function or produce specific neurological outcomes. Our approach is to consider the available scientific evidence, evaluate its quality, and incorporate it as one input into a multi-dimensional formulation framework.